Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 61
J. coloproctol. (Rio J., Impr.) ; 43(2): 126-132, Apr.-June 2023. tab, graf, ilus
Article in English | LILACS | ID: biblio-1514430


Background: Due to few sufficient data regarding the comparison between endoscopic and surgical resection of malignant colorectal polyps regarding outcomes and survival benefits, there are no clear guidelines of management strategies of malignant colorectal polyps. The aims of the present study were to compare endoscopic resection alone and surgical resection in patients with malignant polyps in the colon (T1N0M0) readings advantages, disadvantages, recurrence risks, survival benefits, and long-term prognosis to detect how management strategy affects outcome. Patients and methods: we included 350 patients. All included patients were divided into 2 groups; the first group included 100 patients who underwent only endoscopic polypectomy and the second group included 250 patients who underwent endoscopic polypectomy followed by definitive surgical resection after histopathological diagnosis. We followed all patients for about 5 years, ranging from 18 to 55 months. The primarily evaluated parameters are surgical consequences and patients' morbidity. The secondary evaluated parameters are recurrence risks, recurrence free survival, and overall survival rates. Results: The age of patients who underwent polypectomy is usually younger than the surgical group, males have more liability to polypectomy in comparison with females. Patients with tumors in the left colon have more liability to polypectomy in comparison with the right colon (p< 0.0001). Tumor factors associated with more liability to surgical resection are presence of lymphovascular invasion, high grade, and poor tumor differentiation (p< 0.0001). The management strategy was the most significant predictor of overall and recurrence free survival rates in patients with malignant colon polyps (p< 0.001). Conclusions: We found that survival benefits and lower incidence of recurrence are detected in the surgical resection group more than in the polypectomy group. (AU)

Digestive System Surgical Procedures/methods , Colonic Polyps/surgery , Colonic Neoplasms/mortality , Laparoscopy , Endoscopy , Neoplasm Recurrence, Local , Neoplasm Staging
Rev. ANACEM (Impresa) ; 17(1): 70-76, 2023. tab, ilus
Article in Spanish | LILACS | ID: biblio-1525945


El cáncer colorrectal (CCR) es un problema de salud prevalente y significativo a nivel mundial, especialmente en países desarrollados. Este estudio tuvo como objetivo evaluar la tasa de mortalidad por CCR en Chile en los últimos 25 años. Se llevó a cabo un estudio descriptivo ecológico utilizando datos públicos de mortalidad desde 1997 hasta 2022, que incluyeron un total de 50.944 defunciones. Los resultados revelaron que el cáncer de colon representó la mayoría de los casos (72,15%) donde el colon sigmoide fue el sitio más afectado. La tasa de mortalidad promedio fue de 11,19 por cada 100.000 habitantes, mostrando un aumento significativo a lo largo del tiempo. El análisis por edad indicó una mayor carga de mortalidad en individuos de 75 a 90 años. Se observó disparidades de género, con predominio de muertes femeninas hasta el año 2019. El análisis de la tasa ajustada por región reveló diferencias no significativas en las tasas de mortalidad, siendo Valparaíso y Magallanes y Antártica Chilena las regiones con tasas más altas para el cáncer de colon y el cáncer de recto, respectivamente. Estos hallazgos contribuyen a nuestra comprensión de la epidemiología del CCR en Chile y enfatizan la necesidad de intervenciones específicas en prevención primaria y screening para reducir la mortalidad por esta enfermedad.

Colorectal cancer (CRC) is a prevalent and significant health problem worldwide, especially in developed countries. The aim of this study was to evaluate the CRC mortality rate in Chile in the last 25 years. An ecological descriptive study was carried out using public mortality data from 1997 to 2022, which included a total of 50,944 deaths. The results revealed that colon cancer represented the majority of cases (72.15%) where the sigmoid colon was the most affected site. The average mortality rate was 11.19 per 100,000 individuals, showing a significant increase over time. The analysis by age showed a greater burden of mortality in individuals from 75 to 90 years. Gender disparities were observed, with a predominance of female deaths until 2019. The analysis of the rate configured by region revealed non-significant differences in mortality rates, with Valparaíso and Magallanes and Antártica Chilena being the regions with the highest rates for colon and rectal cancer, respectively. These findings contribute to our understanding of the epidemiology of CRC in Chile and emphasize the need for specific interventions in primary prevention and screening to reduce mortality from this disease.

Humans , Male , Female , Child , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Rectal Neoplasms/mortality , Rectal Neoplasms/epidemiology , Colorectal Neoplasms/mortality , Colorectal Neoplasms/epidemiology , Colonic Neoplasms/mortality , Colonic Neoplasms/epidemiology , Chile/epidemiology , Epidemiology, Descriptive
J. coloproctol. (Rio J., Impr.) ; 40(4): 315-320, Oct.-Dec. 2020. tab, graf
Article in English | LILACS | ID: biblio-1143170


ABSTRACT Background Current threshold for minimum lymph node harvest may not be adequate for appropriate staging in colon cancer and newer surgical techniques may allow more lymph nodes to be harvested. The aim of this study was to examine the prognostic role of harvesting and examining lymph nodes higher in number than the recommended threshold (≥12), in patients with colon cancer. Methods This retrospective study included 179 patients that underwent open colon resection for adenocarcinoma of the colon. A D3 resection with high vascular ligation was made so that large number of lymph nodes was removed in most patients. Differences in overall survival between below and above three cutoff points (≥18, ≥24, ≥40) were estimated. Results During median 33 months of follow-up, 45 patients died and mean overall survival was 108.7 ± 5.6 months (95% CI, 97.7-119.7). The mean number of lymph nodes harvested and examined was 44.0 ± 25.7 (median 38; range, 7-150). No significant effect was found for three different cut-off values (≥18, ≥24, or ≥40 nodes) on mean overall survival (p > 0.05 for all comparisons). The same was true for the whole study population as well as for N0 (N negative) and N1-2 (N positive) patient subgroups, when they are analyzed separately. Conclusions Our findings do not support the survival benefit of substantially higher number of lymph nodes harvested in colon cancer.

RESUMO Fundamento: O limite atual para a coleta mínima de linfonodos pode não ser adequado para o estadiamento adequado no câncer de cólon e novas técnicas cirúrgicas podem permitir que um número maior de linfonodos seja coletado. O objetivo deste estudo foi examinar o papel prognóstico da coleta e exame de linfonodos em número maior do que o limite recomendado (≥ 12), em pacientes com câncer de cólon. Método: Este estudo retrospectivo incluiu 179 pacientes submetidos à ressecção aberta de cólon para adenocarcinoma de cólon. A ressecção D3 com ligadura vascular alta foi realizada para que um grande número de linfonodos fosse removido na maioria dos pacientes. As diferenças na sobrevida global entre abaixo e acima de três pontos de corte (≥ 18, ≥ 24, ≥ 40) foram estimadas. Resultados: Durante a mediana de 33 meses de seguimento, 45 pacientes morreram e a sobrevida global média foi de 108,7 ± 5,6 meses (IC 95%: 97,7-119,7). O número médio de linfonodos coletados e examinados foi de 44,0 ± 25,7 (mediana = 38; variação: 7-150). Nenhum efeito significativo foi encontrado para três valores de corte diferentes (≥ 18, ≥ 24 ou ≥ 40 linfonodos) na sobrevida global média (p >0,05 para todas as comparações). O mesmo foi verdadeiro para toda a população do estudo, bem como para os subgrupos de pacientes N0 (N negativos) e N1-2 (N positivos), quando analisados separadamente. Conclusões: Nossos achados não apoiam o benefício na sobrevida de um número substancialmente maior de linfonodos coletados no câncer de cólon.

Humans , Male , Female , Adenocarcinoma/diagnosis , Colonic Neoplasms/diagnosis , Colonic Neoplasms/mortality , Lymph Node Excision/methods , Prognosis , Survival Analysis
Arq. gastroenterol ; 57(2): 172-177, Apr.-June 2020. tab, graf
Article in English | LILACS | ID: biblio-1131660


ABSTRACT BACKGROUND: Hospital-based studies recently have shown increases in colorectal cancer survival, and better survival for women, young people, and patients diagnosed at an early disease stage. OBJECTIVE: To describe the overall survival and analyze the prognostic factors of patients treated for colorectal cancer at an oncology center. METHODS: The analysis included patients diagnosed with colon and rectal adenocarcinoma between 2000 and 2013 and identified in the Hospital Cancer Registry at A.C.Camargo Cancer Center. Overall 5-year survival was estimated using the Kaplan-Meier method, and prognostic factors were evaluated in a Cox regression model. Hazard ratios (HR) are reported with 95% confidence intervals (CI). RESULTS: Of 2,279 colorectal cancer cases analyzed, 58.4% were in the colon. The 5-year overall survival rate for colorectal cancer patients was 63.5% (65.6% and 60.6% for colonic and rectal malignancies, respectively). The risk of death was elevated for patients in the 50-74-year (HR=1.24, 95%CI =1.02-1.51) and ≥75-year (HR=3.02, 95%CI =2.42-3.78) age groups, for patients with rectal cancer (HR=1.37, 95%CI =1.11-1.69) and for those whose treatment was started >60 days after diagnosis (HR=1.22, 95%CI =1.04-1.43). The risk decreased for patients diagnosed in recent time periods (2005-2009 HR=0.76, 95%CI =0.63-0.91; 2010-2013 HR=0.69, 95%CI =0.57-0.83). CONCLUSION: Better survival of patients with colorectal cancer improves with early stage and started treatment within 60 days of diagnosis. Age over 70 years old was an independent factor predictive of a poor prognosis. The overall survival increased to all patients treated in the period 2000-2004 to 2010-2013.

RESUMO CONTEXTO: Estudos hospitalares recentes têm demonstrado aumento da sobrevida do câncer colorretal e melhor sobrevida para mulheres, jovens e pacientes diagnosticados em estágio precoce da doença. OBJETIVO: Descrever a sobrevida global e analisar os fatores prognósticos de pacientes tratados para câncer colorretal em um centro de oncologia. MÉTODOS: Foram incluídos pacientes com diagnóstico de adenocarcinoma de cólon e reto entre 2000 e 2013, identificados no Registro Hospitalar de Câncer do A.C.Camargo Cancer Center. A sobrevida global aos 5 anos foi estimada pelo método de Kaplan-Meier e os fatores prognósticos foram avaliados pelo modelo de Cox. As razões de risco (HR) são relatadas com intervalos de confiança (IC) de 95%. RESULTADOS: Dos 2.279 casos de câncer colorretal analisados, 58,4% eram de cólon. A taxa de sobrevida global aos 5 anos para pacientes com câncer colorretal foi de 63,5% (65,6% e 60,6% para câncer de cólon e retal, respectivamente). O risco de óbito foi elevado para pacientes na faixa etária de 50-74 anos (HR=1,24; IC95% =1,02-1,51) e ≥75 anos (HR=3,02; IC95% =2,42-3,78), para pacientes com câncer retal (HR=1,37; IC95% =1,11-1,69) e para aqueles cujo tratamento foi iniciado >60 dias após o diagnóstico (HR=1,22; IC95% =1,04-1,43). O risco diminuiu para pacientes diagnosticados em períodos recentes (2005-2009 HR=0,76; IC95% =0,63-0,91; 2010-2013 HR=0,69; IC95% =0,57-0,83). CONCLUSÃO: A sobrevida dos pacientes com câncer colorretal é maior naqueles em estágio inicial e com início do tratamento antes dos 60 dias.. Idade acima de 70 anos foi fator independente preditivo de mau prognóstico. A sobrevida global aumentou para todos os pacientes tratados no período de 2000-2004 a 2010-2013.

Humans , Male , Female , Aged , Aged, 80 and over , Rectal Neoplasms/mortality , Colorectal Neoplasms/mortality , Colonic Neoplasms/mortality , Prognosis , Rectal Neoplasms/pathology , Rectal Neoplasms/therapy , Survival , Severity of Illness Index , Brazil/epidemiology , Colorectal Neoplasms/pathology , Colorectal Neoplasms/therapy , Survival Analysis , Registries , Survival Rate , Retrospective Studies , Colonic Neoplasms/pathology , Colonic Neoplasms/therapy , Middle Aged , Neoplasm Staging , Antineoplastic Agents/therapeutic use
J. health med. sci. (Print) ; 5(1): 35-40, Ene-Mar. 2019. ilus, tab, graf
Article in Spanish | LILACS | ID: biblio-1151838


El tratamiento estándar del cáncer de colon (CC), continúa siendo la resección radical del segmento intestinal comprometido con márgenes libres (al menos 5 cm por encima y debajo del tumor), pudiendo o no asociarse a terapias complementarias. El objetivo de este estudio fue determinar morbilidad postoperatoria (MPO) y supervivencia actuarial global (SVAG) a 5 años en pacientes resecados por CC no complicado. La metodología usada fue serie de casos retrospectiva de pacientes con CC no complicado, sometidos a colectomía subtotal y linfadenectomía, de forma consecutiva, en Clínica RedSalud Mayor Temuco, entre 2007 y 2017. La variable resultado fue SV actuarial global (SVAG) a 5 años. Otras variables de interés fueron: tiempo quirúrgico, número de linfonodos resecados, estancia hospitalaria, MPO, y recurrencia. Los pacientes fueron seguidos de forma clínica. Se utilizó estadística descriptiva, con medidas de tendencia central y dispersión; y análisis de SV con curvas de Kaplan Meier. Se intervinieron 43 pacientes (58,1 % hombres), con una mediana de edad de 66 años. La localización y estadios más frecuentes fueron colon derecho (18 casos, 41,9 %); y IIIA, IIIB, respectivamente. La resecabilidad de la serie fue 100 %. La medianas del tiempo quirúrgico, del número de linfonodos resecados y de estancia hospitalaria; fueron de 100 minutos, 30 y 5 días, respectivamente. La MPO fue 30,2 % (13 casos). Con una mediana de seguimiento de 55 meses, se verificó una recurrencia de 13,9 %; y SVAG a 5 años de 69,8 % para la totalidad de la serie. Los resultados obtenidos, en términos de MPO, mortalidad y SVAG a 5 años, fueron similares a series de nacionales e internacionales.

The standard treatment of colonic cancer (CC) continues to be the radical resection of the intestinal segment compromised with free margins, associated or not with adjuvant therapies. The aim of this study was to determine postoperative morbidity (POM) and 5-year overall survival (OS) in patients resected by non-complicated CC. The methodology used was a series of cases in retrospective of patients with non-complicated CC undergoing colectomy and lymphadenectomy, consecutively, at RedSalud Mayor Temuco Clinic, between 2007 and 2017. The outcome variable was 5-years OS. Other variables of interest were: surgical time, the number of resected lymph nodes, hospital stay, POM, and recurrence. Patients were followed clinically. Descriptive statistics were used (measures of central tendency and dispersion), and OS analysis was applying Kaplan Meier curves. 43 patients (58.1% men) were intervened, with a median age of 66 years. The most frequent localization and stages were the right colon (18 cases, 41.9%); and IIIA, IIIB respectively. Median surgical time, the number of resected lymph nodes and hospital stay were 100 min, 30 and 5 days respectively. MPO was 30.2% (13 cases). With a median follow-up of 55 months, a recurrence of 13.9% was verified, and a 5-year OS of 69.8% was observed. The results, in terms of POM, mortality and 5-year OS, were similar to the national and international series.

Humans , Male , Female , Adult , Aged , Aged, 80 and over , Colonic Neoplasms/surgery , Colonic Neoplasms/physiopathology , Recurrence , Sigmoid Neoplasms/physiopathology , Chile , Follow-Up Studies , Morbidity , Colectomy , Colonic Neoplasms/mortality , Age and Sex Distribution , Kaplan-Meier Estimate , Informed Consent , Length of Stay , Lymph Node Excision/methods
ABCD (São Paulo, Impr.) ; 32(4): e1479, 2019. tab
Article in English | LILACS | ID: biblio-1054602


ABSTRACT Background: Since 1990 it was proposed that distal and proximal location of colon cancer might follow different biological, epidemiology, pathology and prognosis, probably due to embryologic different development of the two segments of the colon, which may represent two separate disease entities. These differences might have consequences for the treatment of patients with colorectal cancer. Aim: To compare the characteristics between patients with right and left colon cancer, with severity and tumor characteristic that influence in the survival of these patients. Method: Were evaluated the outcomes of surgical treatment of patients with colon cancer with data collected retrospectively from prospectively collected database. Results: The tumor's side did not influence survival time of patients with colon cancer (p=0.112) in the regression model. Only the diseases stage leads to influence on survival time; patients with right colon cancer have more advanced staging (III or IV) and present a risk of death greater in 3.23 times. Conclusion: This analysis provides evidence that the prognosis of localized left-sided colon cancer is better compared to right-sided colon cancer. Also, the patients with right colon cancer have more advanced stage, mucinous tumor and are older.

RESUMO Racional: Desde 1990, foi proposto que a localização distal e proximal do câncer de cólon pode seguir diferentes aspectos biológicos, epidemiológicos, patológicos e prognósticos. Essas diferenças podem ter consequências para o tratamento de pacientes com câncer colorretal. Objetivo: Comparar as características entre pacientes com câncer de cólon direito e esquerdo, com gravidade e características tumorais que influenciam na sobrevida desses pacientes. Método: Avaliação dos resultados do tratamento cirúrgico dos pacientes com câncer de cólon em longo prazo com dados coletados retrospectivamente. Resultados: O lado do tumor não influenciou o tempo de sobrevida (p=0,112) no modelo de regressão. Apenas o estágio da doença influencia no tempo de sobrevida. Os pacientes com câncer de cólon direito apresentam estadiamento mais avançado (III ou IV) e apresentam risco de morte 3,23 vezes maior. Conclusão: O prognóstico do câncer de cólon localizado no lado esquerdo é melhor comparado ao direito. Os pacientes com câncer de cólon direito têm estágio e idade mais avançados e tumor mucinoso.

Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Colonic Neoplasms/mortality , Colonic Neoplasms/pathology , Prognosis , Retrospective Studies , Follow-Up Studies , Kaplan-Meier Estimate , Neoplasm Staging
Rev. Col. Bras. Cir ; 46(3): e20192098, 2019. tab, graf
Article in Portuguese | LILACS | ID: biblio-1013162


RESUMO Objetivo: avaliar diferenças clínicas e patológicas entre os adenocarcinomas colônicos localmente avançados com aderências entre órgãos ou estruturas adjacentes (LACA) e adenocarcinomas colônicos com outras apresentações clínicas. Métodos: estudo retrospectivo a partir de amostra de conveniência de pacientes com adenocarcinoma colônico, estádio patológico pT3, distribuídos de acordo com características clínicas e patológicas em três grupos: tumores localmente avançados (LACA), tumores pT3 sem aderências ou metástases à distância (SF), e tumores com doença metastática (M1). Foram avaliadas as características clínicas e patológicas, e a expressão de sete marcadores imuno-histoquímicos relacionados à proliferação/apoptose, invasão celular/migração e metástase. Resultados: foram avaliados 101 pacientes: 30 LACA, 44 SF e 27 M1. Tumores localmente avançados apresentaram dimensões maiores e estiveram associados a aumento das taxas de infiltração linfocitária, menores níveis de expressão de bax e de CD 44v6 quando comparados aos grupos SF e M1. Diferenças significantes foram observadas em relação aos LACA e M1 em relação à localização colônica, histologia, estado linfonodal e expressão bax e CD44v6. Diferenças foram observadas em relação aos três grupos frente ao tamanho do tumor e infiltrado linfocítico. A sobrevida foi similar entre os grupos LACA e SF (p=0,66) e foi inferior no grupo M1 (p<0,001). Conclusão: os dados sugerem que os adenocarcinomas colônicos localmente avançados com aderências entre órgãos ou estruturas adjacentes representam uma entidade distinta.

ABSTRACT Objective: to evaluate the clinical and pathological differences between locally advanced colonic adenocarcinomas (LACA) with adhesions between adjacent organs or structures, and colonic adenocarcinomas with other clinical presentations. Methods: we conducted a retrospective study from a convenience sample of patients with colonic adenocarcinoma, pathological stage pT3, distributed according to clinical and pathological characteristics in three groups: locally advanced tumors (LACA), pT3 tumors without adhesions or distant metastases (SF) and tumors with metastatic disease (M1). We evaluated clinical and pathological characteristics and the expression of seven immunohistochemical markers related to proliferation/apoptosis, cell invasion/migration and metastasis. Results: we studied 101 patients: 30 LACA, 44 SF and 27 M1. Locally advanced tumors presented larger dimensions and were associated with increased lymphocyte infiltration rates, lower levels of bax expression, and CD 44v6 when compared with SF and M1 groups. We observed significant differences between LACA and M1 in relation to colonic location, histology, lymph node status and bax and CD44v6 expression. We found differences were observed between the three groups for tumor size and lymphocytic infiltrate. Survival was similar in the LACA and SF groups (p=0.66) and was lower in the M1 group (p<0.001). Conclusion: the data suggest that locally advanced colonic adenocarcinomas with adhesions between adjacent organs or structures represent a distinct entity.

Humans , Adenocarcinoma/pathology , Colonic Neoplasms/pathology , Immunohistochemistry , Adenocarcinoma/mortality , Survival Analysis , Retrospective Studies , Longitudinal Studies , Colonic Neoplasms/mortality , Neoplasm Metastasis , Neoplasm Staging
J. coloproctol. (Rio J., Impr.) ; 38(1): 24-29, Jan.-Mar. 2018. graf
Article in English | LILACS | ID: biblio-894028


ABSTRACT Introduction: Colorectal cancer is the 4th commonest cancer in the world. Studies had shown different tumor behavior depending on the site, pathology and stage. However the characters of Egyptian colon cancer patients are not well addressed. Method: Computerized registry of a tertiary cancer hospital in Egypt was searched for colon cancer cases. Demographic, pathologic and treatment data were collected and analyzed using SPSS program. Results: About 360 colon cancer patients attended our center in the last 12 years. Tumor characters showed great diverse from that of developed countries, with especially different prognosis and survival. Conclusion: Egyptians have unique tumor characters and behavior, and different compliance with treatment regimens. Multicenter prospective studies, as well as evolving Egyptian treatment guidelines are needed to address this.

RESUMO Introdução: Câncer colorretal é a quarta neoplasia mais comum a nível mundial. Estudos demonstraram diferentes comportamentos do tumor, dependendo do local, da patologia e do estágio. Contudo, ainda não estão devidamente definidas as características dos pacientes egípcios com câncer de cólon. Métodos: Foi realizada pesquisa no registro computadorizado de um hospital terciário para pacientes com câncer, à busca de casos de câncer de cólon. Foi feita coleta de dados demográficos, patológicos e terapêuticos. Tais dados foram então submetidos à análise com o programa SPSS. Resultados: Nos últimos 12 anos, cerca de 360 pacientes portadores de câncer de cólon foram atendidos em nosso Centro. As características dos tumores demonstraram grandes diferenças em comparação com os achados de países desenvolvidos e, em especial, com relação ao prognóstico e à sobrevida. Conclusão: Os egípcios exibem características e comportamentos singulares com relação aos tumores, além de diferentes graus de cooperação com os regimes terapêuticos. Para que tais aspectos sejam sanados, há necessidade de mais estudos prospectivos multicêntricos, bem como de um aprimoramento das diretrizes terapêuticas para os egípcios.

Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Adenocarcinoma/epidemiology , Incidence , Colonic Neoplasms/mortality , Colonic Neoplasms/epidemiology , Survival Rate , Retrospective Studies , Egypt
Buenos Aires; GCBA. Gerencia Operativa de Epidemiología; 30 jun. 2017. a) f: 15 l:26 p. graf, tab.(Boletín Epidemiológico Semanal: Ciudad Autónoma de Buenos Aires, 2, 45).
Monography in Spanish | UNISALUD, BINACIS, InstitutionalDB, LILACS | ID: biblio-1104185


En la actualidad, las enfermedades crónicas no transmisibles (ECNT) constituyen la principal causa de mortalidad mundial. Las enfermedades crónicas se caracterizan por su larga duración, progresividad y curación no previsible, pudiendo requerir tratamiento y control durante una extensa e indeterminada cantidad de años. El cáncer forma parte del grupo de las enfermedades crónicas no transmisibles (ECNT), junto con las enfermedades cardiovasculares, respiratorias crónicas y diabetes. Estas enfermedades, se encuentran entre los problemas más comunes y más costosos para la salud pública de la población. El presente documento describe el comportamiento de la mortalidad global por cáncer y por los principales sitios tumorales, en residentes de la Ciudad de Buenos Aires, según sexo y comunas, en dos quinquenios: 2006-2010 y 2011-2015. En primer lugar se describe la variación de la mortalidad entre los periodos mencionados para las principales causas, en el total de la CABA, según sexo. En segundo lugar, se calcula y se compara la variación de la mortalidad entre los periodos mencionados, en el total y tres principales causas, según sexo y comunas de la Ciudad. Para el análisis de la mortalidad en la CABA se utilizaron las bases provistas por la Dirección de Estadísticas e información en Salud (DEIS) y del Sistema de Vigilancia Epidemiológica y reporte del Cáncer (SIVER/INC). Además, se utilizó como fuente de datos, el "Atlas de mortalidad por cáncer en Argentina 2011-2015", en el capítulo correspondiente a la Ciudad de Buenos Aires

Humans , Male , Female , Adolescent , Adult , Middle Aged , Prostatic Neoplasms/epidemiology , Breast Neoplasms/epidemiology , Catchment Area, Health/statistics & numerical data , Mortality , Colonic Neoplasms/mortality , Colonic Neoplasms/epidemiology , Epidemiological Monitoring , Neoplasms/diagnosis , Neoplasms/mortality , Neoplasms/prevention & control , Neoplasms/epidemiology , Neoplastic Processes
ABCD (São Paulo, Impr.) ; 30(2): 103-107, Apr.-June 2017. tab, graf
Article in English | LILACS | ID: biblio-885704


ABSTRACT Background: Colorectal cancer is the third most common cancer in the world. In Brazil, it is the leading cause of cancer in the gastrointestinal tract. Aim: To evaluate the preoperative, perioperative, and postoperative risk factors for recurrence and overall survival of patients with left colon cancer operated during a ten-year period. Methods: Patients with left colon cancer surgically treated underwent clinical preoperative workout and cancer staging. The following factors were studied: gender, age, tumor location, T stage, lymph node yield, N stage, M stage, histological type, and tumor differentiation. It was analyzed the influence in five-year overall survival. Results: A total of 173 patients underwent left colectomy for colon cancer. There was a slight predominance of male gender with 50.9%. The mean age was 60.8 years old. Fifteen (8.7%) tumors were located at splenic flexure, 126 (72.8%) at sigmoid colon, and 32 (18.5%) at descending colon. The median length of hospital stay was seven days. Mean survival was 47.5 months. At 60 months seven patients (4%) lost follow-up, 38 patients (21.9%) deceased and 135 patients (78%) were alive. Overall survival time was 48 months. Conclusion: Advanced stages (T3-T4, N+ and M+) were the only factors associated with poor long term survival in left colon cancer.

RESUMO Racional: O câncer colorretal é o terceiro câncer mais comum no mundo. No Brasil é a principal causa no trato gastrointestinal. Objetivo: Avaliar os fatores de riscos pré, peri e pós-operatório para recorrência e sobrevida global de pacientes com câncer de cólon esquerdo operado durante um período de dez anos. Métodos: Os pacientes com câncer de cólon esquerdo operados foram retrospectivamente avaliados. Os seguintes fatores foram estudados: gênero, idade, localização do tumor, estádio T, número de linfonodos, estágio N, estágio M, tipo histológico e diferenciação tumoral. Foi analisada a influência desses fatores na sobrevida global de cinco anos. Resultados: 173 pacientes foram submetidos à colectomia para câncer de cólon esquerdo. O gênero masculino predominou com 50,9%. A média de idade foi de 60,8 anos. Quinze (8,7%) tumores foram localizados no ângulo esplênico, 126 (72,8%) no sigmóide e 32 (18,5%) e no descendente. A média do tempo de internação foi de sete dias. A sobrevida média foi de 47,5 meses. Aos 60 meses sete doentes (4%) perderam o seguimento, 38 (21,9%) faleceram e 135 (78%) estavam vivos. O tempo de sobrevida global foi de 48 meses. Conclusão: Os estádios avançados (T3-T4, N e M+) foram os únicos fatores associados à menor sobrevida em longo prazo em câncer de cólon esquerdo.

Humans , Male , Adult , Middle Aged , Colectomy/methods , Colonic Neoplasms/surgery , Prognosis , Time Factors , Survival Rate , Retrospective Studies , Risk Factors , Colonic Neoplasms/mortality , Hospitals, University , Neoplasm Recurrence, Local/epidemiology
Rev. chil. cir ; 69(2): 139-143, abr. 2017. graf, tab
Article in Spanish | LILACS | ID: biblio-844345


Objetivos: Describir las tasas de morbilidad y mortalidad postoperatorias de las resecciones ampliadas de colon en pacientes con tumor en estadio T4b. Material y métodos: Serie de casos, que incluye pacientes con adenocarcinoma colónico clínicamente con compromiso de estructuras adyacentes (T4b), intervenidos de resección multivisceral entre los años 2005 y 2014. Fueron excluidos pacientes con metástasis, con bordes macroscópicamente comprometidos y con datos clínicos incompletos. Las variables resultado fueron la morbilidad y mortalidad postoperatorias a los 30 días. Se aplicó estadística descriptiva. Para las variables categóricas se utilizaron porcentajes, y para las variables continuas se utilizaron la media y mediana como medidas de tendencia central y la desviación estándar o rango como medidas de dispersión. Se aplicó el método de Kaplan-Meier para la sobrevida, y pruebas de Chi cuadrado y log-Rank para el análisis de sobrevida por subgrupos. Resultados: De un universo de 483 pacientes intervenidos por adenocarcinoma colónico, 71 fueron T4b. Se aplicaron criterios de exclusión, resultando una muestra de 46 pacientes. Los órganos más frecuentemente comprometidos fueron: intestino delgado, epiplón, pared abdominal y otro segmento colónico. La morbilidad y mortalidad postoperatorias, de un 21,7 y un 6,5%, respectivamente. Influyeron significativamente en la sobrevida la edad, el antecedente de quimioterapia adyuvante, la presencia de inestabilidad microsatelital y la diferenciación del tumor. Conclusiones: El compromiso multivisceral de los tumores colónicos no es infrecuente, con un 9,5% para nuestra serie. La resección R0 es el tratamiento de elección. Influyen en el pronóstico el tipo histológico y el comportamiento biológico del tumor, así como la quimioterapia adyuvante y la edad del paciente.

Aims: To describe postoperative morbidity and mortality rates in multivisceral resections for T4b colon cancer. Material and methods: Case series of patients diagnosed of T4b colonic adenocarcinoma who underwent multivisceral resection between 2005 and 2014. There were excluded those patients who had metastases, R2 resection and incomplete clinical data. Result variables were morbidity and mortality at 30 days. It was performed descriptive statistic using percentage estimation for categories, average and median for continuous variables and standard deviation or rank as measures of statistical dispersion. It was used Kaplan-Meier method for survival and chi-square and log-Rank for subgroups analysis. Results: From a universe of 483 patients who underwent surgery for colonic adenocarcinoma, whom 71 were staged as T4b, after exclusion criteria were applied it resulted a sample of 46 patients. The small bowel, omentum, abdominal wall and other colonic segment were the more often compromised organs. Postoperative morbidity and mortality were 21.7 and 6.5% respectively. The age, history of adjuvant chemotherapy, presence of microsatellite instability and tumor differentiation had a significant impact in survival. Conclusions: Multivisceral affection in colonic cancer is not uncommon, 9.5% in our series. R0 resection is the treatment of choice. Patient outcome depends on his age, histologic and biologic characteristics of the tumor and adjuvant treatment.

Humans , Male , Female , Adenocarcinoma/surgery , Colonic Neoplasms/surgery , Digestive System Surgical Procedures/methods , Adenocarcinoma/mortality , Colonic Neoplasms/mortality , Survival Analysis , Treatment Outcome
Rev. bras. epidemiol ; 19(4): 779-790, Out.-Dez. 2016. tab, graf
Article in English | LILACS | ID: biblio-843729


ABSTRACT: Objective: To describe the incidence and mortality rates from colon and rectal cancer in Midwestern Brazil. Methods: Data for the incidence rates were obtained from the Population-Based Cancer Registry (PBCR) according to the available period. Mortality data were obtained from the Mortality Information System (SIM) for the period between 1996 and 2008. Incidence and mortality rates were calculated by gender and age groups. Mortality trends were analyzed by the Joinpoint software. The age-period-cohort effects were calculated by the R software. Results: The incidence rates for colon cancer vary from 4.49 to 23.19/100,000, while mortality rates vary from 2.85 to 14.54/100,000. For rectal cancer, the incidence rates range from 1.25 to 11.18/100,000 and mortality rates range between 0.30 and 7.90/100,000. Colon cancer mortality trends showed an increase among males in Cuiabá, Campo Grande, and Goiania. For those aged under 50 years, the increased rate was 13.2% in Campo Grande. For those aged over 50 years, there was a significant increase in the mortality in all capitals. In Goiânia, rectal cancer mortality in males increased 7.3%. For females below 50 years of age in the city of Brasilia, there was an increase of 8.7%, while females over 50 years of age in Cuiaba showed an increase of 10%. Conclusion: There is limited data available on the incidence of colon and rectal cancer for the Midwest region of Brazil. Colon cancer mortality has generally increased for both genders, but similar data were not verified for rectal cancer. The findings presented herein demonstrate the necessity for organized screening programs for colon and rectal cancer in Midwestern Brazil.

RESUMO: Objetivo: Descrever o perfil do câncer de cólon e reto no Centro-Oeste do Brasil. Métodos: Os dados de incidência foram obtidos dos Registros de Câncer de Base Populacional (RCBP) de acordo com o período disponível. Dados sobre os óbitos foram obtidos do Sistema de Informação em Mortalidade (SIM). As taxas de incidência e mortalidade foram calculadas por gênero e grupos etários. As tendências de mortalidade foram analisadas pelo software Joinpoint. Os efeitos de idade-período-coorte foram calculados no software R. Resultados: As taxas de incidência do câncer de cólon variaram de 4,49 a 23,19/100.000, e a mortalidade, de 2,85 a 14,54/100.000. A incidência do câncer de reto variou de 1,25 a 11,18/100.000; a mortalidade, de 0,30 a 7,90/100.000. As tendências de mortalidade por câncer de cólon mostraram um aumento entre homens em Cuiabá, Campo Grande e Goiânia. Para aqueles abaixo dos 50 anos, o aumento foi de 13,2% em Campo Grande. Para aqueles acima dos 50 anos, houve um aumento significante em todas as capitais. Em Goiânia, a mortalidade por câncer de reto em homens aumentou 7,3%. Para mulheres abaixo dos 50 anos em Brasília, o aumento foi de 8,7%, enquanto que para mulheres acima dos 50 anos em Cuiabá foi de 10%. Conclusão: Os dados de incidência do câncer de cólon e reto no Centro-Oeste do Brasil são limitados. A mortalidade por câncer de cólon tem aumentado para ambos os sexos, mas o mesmo não foi verificado para câncer de reto. Os resultados demonstram a necessidade de programas organizados de rastreamento para esta neoplasia no Centro-Oeste.

Humans , Male , Female , Adult , Middle Aged , Aged , Colonic Neoplasms/epidemiology , Rectal Neoplasms/epidemiology , Age Distribution , Brazil/epidemiology , Cities/epidemiology , Colonic Neoplasms/mortality , Incidence , Rectal Neoplasms/mortality , Sex Distribution
Rev. méd. Chile ; 144(2): 145-151, feb. 2016. ilus, graf
Article in Spanish | LILACS | ID: lil-779480


Background: Multiple clinical trials have demonstrated the benefits of adjuvant 5-fluorouracil-based chemotherapy for patients with resectable colon cancer (CC), especially in stage III. Aim: To describe the clinical characteristics of a cohort of CC patients treated at a single university hospital in Chile since 2002, and to investigate if chemotherapy had an effect on survival rates. Material and Methods: Review of a tumor registry of the hospital. Medical records of patients with CC treated between 2002 and 2012 were reviewed. Death certificates from the National Identification Service were used to determine mortality. Overall survival was described using the Kaplan-Meier method. A multivariate Cox proportional hazard regression model was also used. Results: A total of 370 patients were treated during the study period (202 in stage II and 168 in stage III). Adjuvant chemotherapy was administered to 22 and 70% of patients in stage II and III respectively. The median follow-up period was 4.6 years. The 5-year survival rate for stage II patients was 79% and there was no benefit observed with adjuvant chemotherapy. For stage III patients, the 5-year survival rate was 81% for patients who received adjuvant chemotherapy, compared to 56% for those who did not receive chemotherapy (hazard ratio (HR): 0.29; 95% confidence interval (CI): 0.15-0.56). The benefit of chemotherapy was found to persist after adjustment for other prognostic variables (HR: 0.47; 95% CI: 0.23-0.94).Conclusions: Patients with colon cancer in stage III who received adjuvant chemotherapy had a better overall survival.

Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Colonic Neoplasms/drug therapy , Fluorouracil/administration & dosage , Prognosis , Survival Rate , Retrospective Studies , Treatment Outcome , Chemotherapy, Adjuvant , Colonic Neoplasms/mortality , Colonic Neoplasms/pathology , Neoplasm Staging
Acta cir. bras ; 31(supl.1): 34-39, 2016. tab, graf
Article in English | LILACS | ID: lil-779758


PURPOSE: In this paper we report clinical variables on colon cancer series. Oncological outcomes were compared to low-income and high-income countries. METHODS: We analysed a prospective database of 51 colon cancer patients submitted to primary tumor resection between 2010 and 2011, showing clinical variables and oncologic outcomes. RESULTS: R0 resection obtained in 80.4%, 21.6% of patients was TNM stage IV, and only 13.7% showed TNM stage I. Disease-free survival was 32 months, overall survival was 46 months, and the tumoral recurrence rate was 9.8%. Univariate analysis showed association of serum CEA levels ≥ 5 ng/dl (p= 0.004), presence of metastasis at diagnosis (p= 0.012), compromised surgical margins (p < 0.001) and poorer tumor differentiation (p= 0.041) to death. Multivariate analysis identified compromised surgical margins as an independent risk factor for death due to colon cancer (P=0.003; odds ratio=0.36; 95% confidence interval=0.004-0.33). Nowadays, 62.7% of patients are alive. CONCLUSION: Recurrence rate, disease-free survival and overall survival was similar to those observed in more developed countries. Serum CEA levels ≥ 5 ng/dl, the presence of metastasis at diagnosis, compromised surgical margins and poorer tumor differentiation were associated with death. A compromised surgical margin was the only independent risk factor for death.

Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Colonic Neoplasms/surgery , Colonic Neoplasms/mortality , Prognosis , Time Factors , Brazil , Carcinoembryonic Antigen/blood , Developed Countries , Multivariate Analysis , Prospective Studies , Risk Factors , Databases, Factual , Colonic Neoplasms/pathology , Developing Countries , Kaplan-Meier Estimate , Income , Lymphatic Metastasis , Neoplasm Recurrence, Local
Medisan ; 19(6)jun.-jun. 2015.
Article in Spanish | LILACS, CUMED | ID: lil-752951


Aproximadamente hasta 30 % de todos los pacientes con cáncer de colon, intervenidos con intención curativa, presentarán enfermedad recurrente, la cual puede provocar la muerte o motivar nuevos tratamientos con alto grado de morbilidad, sin que se haya logrado definir un modelo efectivo sobre la conducta a seguir, habida cuenta que aún no existen criterios uniformes con respecto a su prevención, tratamiento y seguimiento posoperatorio luego de la cirugía inicial, por cuanto se desconocen las posibilidades reales de supervivencia y las causas asociadas a la mortalidad. Sobre la base de tales reflexiones, se revisó la bibliografía pertinente sobre algunas cuestiones elementales al respect.

Approximately up to a 30% of patients with colon cancer, surgically treated with healing aims, will have a recurrent disease, which can cause death or motivate new treatments with high morbidity degree, without achieving yet a definite and effective model on the behaviour to be followed, taking into account that there are no uniform approaches with regard to its prevention, treatment and postoperative follow-up after the initial surgery, so that the real possibilities of survival and the causes associated with mortality are ignored. On the basis of such conclusions, the pertinent literature was reviewed on some elementary questions in this respect.

Colonic Neoplasms , Colonic Neoplasms/diagnosis , Radiotherapy , Colonic Neoplasms/mortality , Drug Therapy , Immunotherapy
Journal of Gynecologic Oncology ; : 293-302, 2015.
Article in English | WPRIM | ID: wpr-123437


OBJECTIVE: To evaluate the prevalence and features of non-endometrial cancers in Thai endometrial cancer (EC) patients. METHODS: EC patients treated in our institution were identified and the following data were collected: age, EC stage, histopathology, adjuvant therapy, other cancers, living status, and cause of death. RESULTS: The mean age of the 344 patients was 56.8+/-10.8 years. Fifty (14.5%) had other synchronous and metachronous cancers. Mean ages of the patients with or without other cancers were not significantly different, 55.7+/-10.04 years versus 57.1+/-11.0 years, respectively (p=0.358). History of any cancer in the family and tumor in the lower uterine segment were more frequent among the patients with other cancers (6.0% vs. 1.7%, p=0.095; 12.0% vs. 1.0%, p or =2 other cancers. Ovarian, breast, and colon were the three most common other cancers. After a median follow-up of 57.1 months, 18.3% of patients had died: 30.0% of patients with other cancers and 16.3% of those without other cancers. The corresponding EC deaths were 14.0% and 11.2%. The 5-year overall survival was significantly lower in patients who had other cancers: 79.3% (95% confidence interval [CI], 68.3 to 90.3) vs. 86.0% (95% CI, 81.7 to 90.3) than in those without (p=0.023). However, the corresponding disease-specific survival was not significantly different: 85.1% (95% CI, 75.5 to 94.7) compared with 89.0% (95% CI, 85.1 to 92.9), respectively (p=0.514). CONCLUSION: Thai EC patients had a high incidence of other cancers. Overall survival of EC patients who had other cancers was worse than those without, while disease-specific survival was not significantly different.

Female , Humans , Middle Aged , Breast Neoplasms/mortality , Chemotherapy, Adjuvant/methods , Colonic Neoplasms/mortality , Disease-Free Survival , Endometrial Neoplasms/mortality , Kaplan-Meier Estimate , Neoplasm Recurrence, Local/mortality , Neoplasms, Multiple Primary/mortality , Neoplasms, Second Primary/mortality , Radiotherapy, Adjuvant/methods , Tertiary Care Centers/statistics & numerical data , Thailand/epidemiology
Rev. méd. Chile ; 141(5): 602-608, mayo 2013. graf, tab
Article in Spanish | LILACS | ID: lil-684368


Background: The neutrophil/lymphocyte ratio is an effective marker of inflammation ana can have prognostic value in surgical patients. Aim: To evaluate the effect of an increased neutrophil/lymphocyte ratio (NLR) on perioperative complications ana overall ana disease-free survival in patients undergoing elective resection for stage II colon cancer. Material and Methods: Data was obtained from clinical charts, preoperative blood results and hospital records of all patients undergoing an elective curative resection for colon cancer, between 2000 and 2007. Preoperative NLR was calculated. Follow-up was obtained from a prospectively maintained colorectal cancer database, clinical records and questionnaires. Uni and multivariable analysis were performed to identify associations, and survival analysis was performed using Kaplan-Meier curves. Results: One hundred twenty two patients with a mean age of69years (52% males), were evaluated. Median follow-up was 73 months, and overall survival for 1 and 5years was 95% and 68%, respectively. On a multivariable analysis after adjusting for age, sex, tumor depth invasion, use of adjuvant therapies and American Society of Anesthesiology preoperative risk score, an NLR > 5 was associated with an increased perioperative complication rate (odds ratio: 3,06, p = 0,033). Kaplan-Meier survival analysis showed a worse overall and disease-free survival for patients with NLR greater than five. Conclusions: A preoperative NLR of five or more is associated with greater perioperative morbidity and worse oncological outcomes in patients undergoing resection for elective stage II colon cancer.

Aged , Female , Humans , Male , Colonic Neoplasms/blood , Lymphocytes , Neutrophils , Colonic Neoplasms/mortality , Colonic Neoplasms/surgery , Disease-Free Survival , Follow-Up Studies , Kaplan-Meier Estimate , Leukocyte Count , Multivariate Analysis , Neoplasm Staging , Prognosis
Arq. gastroenterol ; 50(1): 64-69, Jan-Mar/2013. tab, graf
Article in English | LILACS | ID: lil-671334


Context Several international studies have observed a correlation between the improvement of socio-demographic indicators and rates of incidence and mortality from cancer of the colon and rectum. Objective The objective of this study is to estimate the correlation between average per capita income and the rate of colorectal cancer mortality in Brazil between 2001 and 2009. Methods We obtained data on income inequality (Gini index), population with low incomes (½ infer the minimum wage/month), average family income, per capita ICP and mortality from colon cancer and straight between 2001-2009 by DATASUS. A trend analysis was performed using linear regression, and correlation between variables by Pearson's correlation coefficient. Results There was a declining trend in poverty and income inequality, and growth in ICP per capita and median family income and standardized mortality rate for colorectal cancer in Brazil. There was also strong positive correlation between mortality from this site of cancer and inequality (men r = -0.30, P = 0.06, women r = -0.33, P = 0.05) income low income (men r = -0.80, P<0.001, women r = -0.76, P<0.001), median family income (men r = 0.79, P = 0.06, women r = 0.76, P<0.001) and ICP per capita (men r = 0.73, P<0.001, women r = 0.68, P<0.001) throughout the study period. Conclusion The increase of income and reducing inequality may partially explain the increased occurrence of colorectal cancer and this is possibly due to differential access to food recognized as a risk factor, such as red meat and high in fat. It is important therefore to assess the priority of public health programs addressing nutrition in countries of intermediate economy, as is the case of Brazil. .

Contexto Diversos estudos internacionais têm observado uma correlação entre a melhora dos indicadores sociodemográficos e as taxas de incidência e mortalidade por câncer de cólon e reto. Objetivo O objetivo do presente estudo é estimar a correlação entre renda média per capita e a taxa de mortalidade por câncer colorretal no Brasil entre 2001 e 2009. Métodos Obteve-se os dados de desigualdade de renda (índice de Gini), população que vive com baixa renda (inferir a ½ salário mínimo/mês), renda média familiar, PIB per capita e taxa de mortalidade por câncer de cólon e reto entre 2001 e 2009 através do DATASUS. A análise de tendência foi realizada através do método de regressão linear, e a correlação entre as variáveis através do coeficiente de correlação de Pearson. Resultados Observou-se tendência ao declínio da pobreza e da desigualdade de renda, e incremento no PIB per capita e na renda média familiar e na taxa de mortalidade padronizada de câncer de cólon e reto no Brasil. Observou-se, ainda, correlação fortemente positiva entre a mortalidade por este sítio de câncer e desigualdade (homens r = -0,30, P = 0,06; mulheres r = -0,33, P = 0,05) de renda baixa renda(homens r = -0,80, P<0,001; mulheres r = -0,76, P<0,001), renda média familiar (homens r = 0,79, p = 0,06; mulheres r = 0,76, P<0,001) e PIB per capita (homens r = 0,73, P<0,001; mulheres r = 0,68, P<0,001) em todo o período estudado. Conclusão O incremento da renda e a redução da desigualdade podem parcialmente explicar o aumento da ocorrência do câncer de cólon e reto e isso possivelmente se deve ao acesso diferenciado ...

Female , Humans , Male , Colonic Neoplasms/mortality , Income/statistics & numerical data , Rectal Neoplasms/mortality , Brazil/epidemiology , Incidence , Risk Factors
Arq. gastroenterol ; 48(4): 270-275, Oct.-Dec. 2011. ilus, tab
Article in English | LILACS | ID: lil-607508


OBJECTIVES: To evaluate the incidence surgical results and prognostic factors of locally advanced colorectal cancer. METHODS: Cohort study including 679 colorectal cancer patients treated from 1997 to 2007. Clinical, surgical and histological data were analyzed. RESULTS: Ninety patients (females 61 percent; median age 59 years) were treated for locally advanced carcinomas (13.2 percent), either in the colon (66 percent) or rectum (34 percent). Extended resections most commonly involved the small bowel (19.8 percent), bladder (16.4 percent), uterus (12.9 percent) and ovaries (11.2 percent). Postoperative morbidity and mortality occurred in 23 (25.6 percent) and 3 (3.3 percent) patients, respectively. Survival and recurrence analysis among 76 R0 (84.4 percent) procedures revealed a 60 percent 5-year survival and 34 percent local recurrence rates. Survival curves demonstrated reduced rates for rectal location (45 percent vs 65 percent), tumor depth (50 percent for T4 vs 75 percent for T3), vascular/ lymphatic/perineural invasion (35 percent vs 80 percent) and lymph node metastasis (35 percent vs 80 percent). CONCLUSIONS: Locally advanced carcinomas were found in 13.2 percent of patients. Survival rates were negatively affected by rectal location and adverse histological features. Number of involved organs and neoplastic adhesions did not influenced chances of survival. A radical R0 extended resection was achieved in a high proportion of cases, resulting in a 60 percent cancer-free survival under acceptable operative risks.

OBJETIVOS: Avaliar a incidência, os resultados operatórios e os fatores prognósticos relacionados aos tumores colorretais localmente avançados. MÉTODOS: A população deste estudo foi constituída por 679 pacientes com câncer colorretal tratados entre 1997 e 2007. Dados clínicos, cirúrgicos e histológicos foram analisados. RESULTADOS: Noventa pacientes (mulheres 61 por cento; idade media 59 anos) foram tratados por câncer colorretal localmente avançados (13.2 por cento) no cólon (66 por cento) ou no reto (34 por cento). As ressecções alargadas mais frequentemente envolveram o intestino delgado (19.8 por cento), bexiga (16.4 por cento), útero (12.9 por cento) e ovários (11.2 por cento). Houve morbidade e mortalidade pós-operatórias em 23 (25.6 por cento) e 3 (3.3 por cento) pacientes, respectivamente. Análise de sobrevida e recidiva entre 76 ressecções R0 (84.4 por cento) mostraram sobrevida de 5 anos em 60 por cento e índice de recidiva local em 34 por cento. As curvas de sobrevida demonstraram índices menores para localização retal do tumor (45 por cento vs 65 por cento), grau de penetração (50 por cento para T4 vs 75 por cento para T3), invasão vascular, linfática ou perineural (35 por cento vs 80 por cento) e metástases linfonodais (35 por cento vs 80 por cento). CONCLUSÕES: Carcinomas localmente avançados foram diagnosticados em 13.2 por cento dos pacientes. Os índices de sobrevida foram negativamente afetados pela localização retal e fatores histológicos adversos. O número de órgãos envolvidos e aderências neoplásicas não influenciaram as chances de cura. Foi possível realizar ressecções alargadas R0 em grande proporção de casos, resultando em sobrevida livre de doença em 60 por cento dos doentes, em condições de risco cirúrgico aceitável.

Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult , Colonic Neoplasms/surgery , Rectal Neoplasms/surgery , Colonic Neoplasms/mortality , Colonic Neoplasms/pathology , Neoplasm Invasiveness , Neoplasm Recurrence, Local , Neoplasm Staging , Postoperative Complications , Prognosis , Prospective Studies , Rectal Neoplasms/mortality , Rectal Neoplasms/pathology , Survival Analysis
Rev. chil. cir ; 63(5): 845-892, oct. 2011. ilus, tab
Article in Spanish | LILACS | ID: lil-602999


Background: The lymph node ratio in malignant tumors corresponds to the ratio between the number of involved lymph nodes and the number of examined lymph nodes. This ratio may be a good prognostic index in stage III colon cancer. Aim: To compare the lymph node ratio with the absolute number of positive lymph nodes as prognostic factors in stage III colon cancer. Material and Methods: Analysis of 115 patients aged 25 to 91 years (63 percent women) with a stage III colon cancer operated between 1991 and 2007. Survival according to the absolute number of positive lymph nodes and the lymph node index was calculated. The area under receiver operating characteristic (ROC) curves obtained after a COX regression analysis of survival, was used to analyze the prognostic value of each parameter. Results: Lymph node involvement was classified as T2 in three, T3 in 93 and T4 in 19 patients. The mean number of positive lymph nodes was 3.4 (range 1 to 34) and the mean lymph node index was 0.237 +/- 0.197 (range 0.031-0.882). Seventy four percent of patients had one to three positive lymph nodes and 24 percent had more than three. During a mean follow up of 67 months (range 5-216), 29 patients died. In survival analysis, the area under the ROC curve for the number of involved lymph nodes (0.703, 95 confidence intervals (CI) 0.58-0.82) was slightly better than the area for lymph node index (0.69, 95 percent CI 0.57-0.81). Using a dichotomy analysis, a lymph node index over 0.31 had a higher discriminating value for survival (odds ratio (OR) 19.96 91 percent CI 1.51-253.6) than the presence of 12 or more involved lymph nodes (OR 2.55 95 percent CI 0.86-7.55). Conclusions: The lymph node index and the absolute number of involved lymph nodes are prognostic factors in stage III colon cancer.

Introducción: El índice ganglionar (IG) se ha propuesto como un factor pronóstico mejor que el número de LN positivos en cáncer de colon estadio III. El objetivo es comparar estos factores en una serie clínica. Pacientes y Método: Se incluyen todos los pacientes estadio III resecados con intención curativa (R0). Se compara la sobrevida según el número de LN positivos y el IG mediante el análisis de las curvas ROC. Resultados: Se trata de 115 pacientes con un promedio de edad de 67,9 años (extremos 25-91), el 63,4 por ciento mujeres. El compromiso en profundidad del tumor fue T2 en 3 casos, T3 en 93 casos y T4 en 19. El promedio de ganglios positivos fue 3,4 (extremos 1-34). El índice ganglionar promedio fue 0,237 (DE: 0,197; extremos 0,031-0,882) y la mediana fue 0,1666. El 74 por ciento de los pacientes tenía 1 a 3 ganglios positivos (N1) y el 26 por ciento 4 o más ganglios positivos (N2). El seguimiento promedio fue de 67 meses (extremos 5-216), durante el cual fallecen 29 pacientes. El área bajo la curva ROC del número de LN afectados (0,703; IC 95 por ciento:0,58-082) fue levemente mayor que el área bajo la curva ROC del IG (0,690; IC 95 por ciento:0,57-0,81) (p = 0,63). Al compararlas en forma dicotómica, el IG (OR: 19,96; IC 95 por ciento:1,51-253,6) muestra una mayor capacidad de discriminación que el número de LN afectados (OR: 2,55; IC 95 por ciento: 0,86-7,55). Conclusión: El número de LN metastásicos y el IG son factores pronósticos relevantes en la planificación de la adyuvancia del cáncer de colon estadio III.

Humans , Male , Adult , Female , Middle Aged , Aged, 80 and over , Adenocarcinoma/surgery , Adenocarcinoma/pathology , Lymphatic Metastasis , Colonic Neoplasms/surgery , Colonic Neoplasms/pathology , Adenocarcinoma/mortality , Follow-Up Studies , Neoplasm Staging , Colonic Neoplasms/mortality , Prognosis , Remission Induction , ROC Curve , Survival Analysis